During EMT, tumor cells acquired highly aggressive capabilities and lost expression of epithelial markers, such as E-cadherin, and increased expression levels of mesenchymal markers, such as N-cadherin, Snail, and Vimentin [38]. The gene discussed is CDH1; the disease is neoplasm.